ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes.

Racioppi, Marco

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes. [electronic resource] - BMC cancer Dec 2018 - 1224 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1471-2407

10.1186/s12885-018-5134-7 doi


Administration, Intravesical
Aged
Antibiotics, Antineoplastic--administration & dosage
Female
Follow-Up Studies
Humans
Infusion Pumps--trends
Male
Middle Aged
Mitomycin--administration & dosage
Mycobacterium bovis
Neoplasm Invasiveness--pathology
Prospective Studies
Risk Factors
Salvage Therapy--methods
Time Factors
Treatment Failure
Urinary Bladder Neoplasms--diagnosis